Original document(5 pages)  中文版
    The present invention discloses preparation process of superfine medicine powder with improved water solubility and its orally taken preparation. The preparation process of the superfine medicine powder includes the following steps: dissolving crude medicine powder in ethanol, dropping water solution of polyglycol-4000 or polyglycol-6000 while stirring, setting for 10-120 min, centrifuging at 4000 rpm for 30-60 min to obtain precipitate, and decompression drying the precipitate to obtain the superfine medicine powder with 2 times over raised water solubility. The superfine medicine powder with improved water solubility is used in preparing orally taken preparation with fast in vivo absorption, high bioavailability and low dosage.
Application Number
申请号		 200610015710 Application Date
申请日		 2006.09.20
Title 名称 Prepn process of superfine medicine powder with improved water solubility and its orally taken prepn
Publication Number
公开号		 1931135 Publication Date
公开日		 2007.03.21
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K9/14;A61K9/16;A61K9/20;A61K9/48;A61K47/34;A61K31/7048;A61K31/7052;A61K31/56;A61K31/426;A61K31/337
Applicant(s) Name
申请人		 Tianjin Univ.
Address 地址
Inventor(s) Name 发明人
Attorney & Agent 代理人 luyi
More information 更  多  信  息


 Related patents information
Gastric 5-fluorouracil double slow release tablet of float and stay type for curing gastric cancer
New type floating retention slow release tablet not depending on acidity environment in stomach
Construction of 5-fluorouracil chitosan minipill for filling to inside of the bladder to treat bladder cancer
Oral dissolved Brufen tablet and its preparing method
Colon-targeting oral compound rubarb preparation
Method for preparing protein or polypeptide medicine slow-releasing microball
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.